Month: March 2012
CMA Joins Amicus Brief Protesting Blagojevich Rule
Read More: CMA Joins Amicus Brief Protesting Blagojevich RuleOn Friday, March 23, the Catholic Medical Association joined several other organizations in a brief filed in the Illinois appellate court against the “Blagojevich Rule,” a regulation that would force Illinois pharmacists to dispense abortion-inducing drugs despite their religious and moral convictions. “At a time when there is a critical shortage of pharmacists, a regulation…
St Patricks Day Massacre Closes the Noose
Read More: St Patricks Day Massacre Closes the NooseLast Friday night, on the eve of St. Patrick’s Day, the Obama administration issued important new rules to extend and finalize their abortifacient and contraceptive mandate, issuing demands to provide free sterilizations, contraceptives, and abortifacient pills to all college students. And that is not all . . .
Search
Popular Posts
Catholic Medical Association Deeply Concerned About FDA’s Approval of First OTC Oral Contraceptive
Philadelphia, Pa. – July 13, 2023 – The Catholic Medical Association (CMA) expresses deep concern regarding the decision by the Food and Drug Administration (FDA) to approve the first over the counter (OTC) hormonal contraceptive, Opill. “Given the extensive medical studies demonstrating the risks and adverse effects of hormonal contraceptives, CMA is disappointed and concerned for…
Catholic Medical Association Calls for Authentic Catholic Health Care
Philadelphia, Pa. – June 30, 2023 – The Catholic Medical Association (CMA), the largest association of Catholic medical professionals, calls for all Catholic hospitals and health systems to provide authentic health care in accordance with Church teaching. At a time of rapid advancement in technology and moral relativism influencing clinical practices, it is essential for…
Catholic Medical Association Statement on FDA Support of Making Birth Control Available Over the Counter
Philadelphia, PA- May 11, 2023- Catholic Medical Association (CMA) expresses its deep concern and disappointment regarding the decision by a Food and Drug Administration (FDA) advisory panel to support over-the-counter (OTC) availability of hormonal contraceptives. “Given the extensive medical studies demonstrating the risks and adverse effects of hormonal contraceptives, CMA is disappointed and concerned for the health…